These blue pills comprise the Zantac heartburn drug recall in 2020.

Zantac Heartburn Drug Recall in 2020, Due to Carcinogens

The Zantac heartburn drug recall recently took place in April 2020 by the U.S. Food & Drug Administration (FDA) because of unacceptable levels of a probable carcinogen. Zantac, known generically as ranitidine, is a drug prescribed more than 15 million times a year to patients for heartburn worldwide since 1983. Multiple manufacturers had already issued …

Zantac Heartburn Drug Recall in 2020, Due to Carcinogens Read More »